0001209191-20-062314.txt : 20201208 0001209191-20-062314.hdr.sgml : 20201208 20201208170030 ACCESSION NUMBER: 0001209191-20-062314 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201205 FILED AS OF DATE: 20201208 DATE AS OF CHANGE: 20201208 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DesJardin Michael A. CENTRAL INDEX KEY: 0001512985 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35238 FILM NUMBER: 201375994 MAIL ADDRESS: STREET 1: C/O JAZZ PHARMACEUTICALS, INC. STREET 2: 3180 PORTER DRIVE CITY: PALO ALTO STATE: CA ZIP: 94304 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Horizon Therapeutics Public Ltd Co CENTRAL INDEX KEY: 0001492426 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: L2 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: CONNAUGHT HOUSE, 1ST FLOOR STREET 2: 1 BURLINGTON ROAD CITY: DUBLIN STATE: L2 ZIP: 4 BUSINESS PHONE: 011-353-1-772-2100 MAIL ADDRESS: STREET 1: CONNAUGHT HOUSE, 1ST FLOOR STREET 2: 1 BURLINGTON ROAD CITY: DUBLIN STATE: L2 ZIP: 4 FORMER COMPANY: FORMER CONFORMED NAME: Horizon Pharma plc DATE OF NAME CHANGE: 20140919 FORMER COMPANY: FORMER CONFORMED NAME: HORIZON PHARMA, INC. DATE OF NAME CHANGE: 20100520 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-12-05 0 0001492426 Horizon Therapeutics Public Ltd Co HZNP 0001512985 DesJardin Michael A. C/O HORIZON THERAPEUTICS PLC, CONNAUGHT HOUSE 1ST FL, 1 BURLINGTON RD DUBLIN L2 4 IRELAND 0 1 0 0 EVP, Technical Operations Ordinary Shares 2020-12-05 4 M 0 5861 A 72207 D Ordinary Shares 2020-12-05 4 F 0 2906 71.72 D 69301 D Restricted Stock Units 2020-12-05 4 M 0 5861 0.00 D Ordinary Shares 5861 0 D Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer. Includes 1,987 ordinary shares of the Issuer which were acquired pursuant to an employee stock purchase program, including 1,005 ordinary shares acquired on June 1, 2020 and 982 ordinary shares acquired on December 1, 2020. Reflects the net settlement of ordinary shares of the Issuer in connection with the vesting of restricted stock units. On December 15, 2016, the reporting person was granted 23,442 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the vesting commencement date of December 5, 2016. /s/ Miles W. McHugh, Attorney-in-Fact 2020-12-08